Bristol Myers Squibb, a global biopharmaceutical company headquartered in Princeton, NJ, is dedicated to pioneering innovations in cancer treatments to transform the lives of patients. With a focus on research and development in areas such as immunology and oncology, Bristol Myers Squibb collaborates with partners worldwide to advance cell therapy and drive diversity in clinical trials.
The company's commitment to global inclusion and diversity is evident in its efforts to close the diversity gap in clinical trials and support women in STEM fields. Through strategic research approaches and a dedication to patient outcomes, Bristol Myers Squibb continues to lead the way in developing cutting-edge medicines for a variety of healthcare needs.
Generated from the website